We have recently described that luminal breast cancer cells widely express MUC1 and exhibit a low level of EGFR in situ, whereas triple-negative breast cancer cells are negative for MUC1 and positive for EGFR21. This evidence concerns the gene MUC1 and breast carcinoma.